glp-1 hormone weight loss Glucagon-like peptide-1 receptor: mechanisms and advances in therapy GLP-1: Genetic Variants Related to

These preclinical findings support clinical trial results showing that tirzepatide, a dual GIPR/GLP-1R agonist, exhibits greater anti-obesity effects than GLP-1 receptor agonists alone

When patients hear that real people in a structured program saw broad systemic improvement after one year, it reframes the conversation from a weight loss drug to metabolic medicine with meaningful outcomes.

Altered adipose tissue DNA methylation status in metabolic syndrome: relationships between global DNA methylation and specific methylation at adipogenic, lipid metabolism and inflammatory candidate genes and metabolic variables

People with MEN2A or MEN2B should avoid GLP-1 drugs entirely

Treatment of osteoarthritis with incretin hormones or analogues thereof

PlexusDx offers both formats, allowing you to select the method that aligns with your preferences and health priorities